Applied DNA Reports Third Quarter Fiscal 2022 Financial Results
August 11th, 2022
Tag: Investor
APDN Receives ~$3.6 Million in Net Proceeds from Warrant Exercise
August 9th, 2022
APDN to Host Conference Call and Webcast Discussing FQ3’22 Results
August 8th, 2022
APDN Announces Closing of $12M Upsized Public Offering
August 8th, 2022
APDN Announces Pricing of $12M Upsized Public Offering
August 4th, 2022
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 12th, 2022
APDN Schedules FY’22 Q2 Results Conference Call & Webcast
May 9th, 2022
Applied DNA to Participate in 2022 Maxim Virtual Growth Conference
March 23rd, 2022
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
February 25th, 2022